Key result
Simultaneous myocardial revascularization with correction of moderate ischemic mitral regurgitation presents both advantages and disadvantages, with off-pump approaches proposed for high-risk patients.
Why the study?
What are the optimal surgical treatment strategies for patients with moderate ischemic mitral insufficiency?
What are the optimal surgical treatment strategies for patients with moderate ischemic mitral insufficiency?
This review outlines current concepts and strategies for the surgical management of moderate ischemic mitral regurgitation, including simultaneous correction and off-pump revascularization.
Individualized decisions remain essential for moderate ischemic MR; leaves open optimal simultaneous versus staged strategies pending higher-level evidence.
Ischemic mitral regurgitation is a widespread mitral valve pathology associated with left ventricular remodeling due to coronary disease in patients with normal valvular anatomy. It’s incidence continues to rise together with the improvement in survival after myocardial infarction. The presence of mitral regurgitation has a direct impact on treatment results and long-term quality of life after coronary artery bypass grafting. Owing to the new methods of instrumental and laboratory diagnostics development its pathophysiology is now well understood. Nevertheless, prior strategy working-out (especially in patients with moderate mitral regurgitation) remains one of the most actual and disputed questions. Current review shows several conceptions to solve this problem. There are some advantages and disadvantages of simultaneous myocardium revascularization with correction of moderate mitral valve disease. Under certain conditions, particularly in high risk patients, off-pump myocardial revascularization is proposed.
No takes yet. Share an insight, caveat, or question.
Хубулава et al. (2013) conducted a review in Moderate ischemic mitral insufficiency. Simultaneous myocardium revascularization with mitral valve correction was evaluated. Simultaneous myocardial revascularization with correction of moderate ischemic mitral regurgitation presents both advantages and disadvantages, with off-pump approaches proposed for high-risk patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: